CHULALONGKORN UNIVERSITY

🇹🇭Thailand

Country: 🇹🇭Thailand

Ownership: -

Established: 1917-01-01

Employees: -

Market Cap: -

Website: https://www.chula.ac.th/

Clinical Trials

Effect of Banana Blossom on Breast Milk Volume in Mothers of Preterm Newborns

Phase 4

Completed

Conditions: Preterm Birth
Postpartum Women

Interventions: Drug: Banana Blossom
Drug: Placebo

First Posted Date: 2022-07-19

Last Posted Date: 2024-02-07

Lead Sponsor: Chulalongkorn University

Target Recruit Count: 70

Registration Number: NCT05465460

Locations: 🇹🇭
Vorapong Phupong, Bangkok, Thailand

A Study of Fixed Dose Versus Serum Level-Based Titration Regimen of Vitamin D Supplementation in Dialysis Patients

Not Applicable

Completed

Conditions: Vitamin D Deficiency
End Stage Renal Disease

Interventions: Other: ergocalciferol supplementation
Other: dialysis techniques
Other: sunlight exposure time

First Posted Date: 2022-06-28

Last Posted Date: 2024-02-08

Lead Sponsor: Chulalongkorn University

Target Recruit Count: 78

Registration Number: NCT05434377

Locations: 🇹🇭
Chulalongkorn Univeristy, Bangkok, Thailand

Leptospirosis Care Bundle Study

Not Applicable

Recruiting

Conditions: Leptospirosis

Interventions: Procedure: Care Bundle

First Posted Date: 2022-06-21

Last Posted Date: 2023-05-23

Lead Sponsor: Chulalongkorn University

Target Recruit Count: 300

Registration Number: NCT05425524

Locations: 🇹🇭
Chulalongkorn university, Bangkok, Thailand

The Role of Blood Purification by Hemoadsorption as Adjunctive Treatment in Children With Septic Shock

Not Applicable

Completed

Conditions: Septic Shock
Multi Organ Failure

Interventions: Device: HA330 hemoadsorption technique

First Posted Date: 2022-06-02

Last Posted Date: 2022-06-02

Lead Sponsor: Chulalongkorn University

Target Recruit Count: 10

Registration Number: NCT05401695

Locations: 🇹🇭
Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand

Calcium From Fish Bone in Volunteers With Osteopenia

Not Applicable

Conditions: Osteopenia

Interventions: Dietary Supplement: Calcium carbonate
Dietary Supplement: Calcium from fish bone

First Posted Date: 2022-05-19

Last Posted Date: 2022-05-19

Lead Sponsor: Chulalongkorn University

Target Recruit Count: 48

Registration Number: NCT05381168

The Effects of Empagliflozin on Renal Outcomes in Post Severe Acute Kidney Injury Survivors

Phase 1

Recruiting

Conditions: Empagliflozin in Post AKI Stage 2-3

Interventions: Drug: Empagliflozin 10 MG
Drug: Placebo

First Posted Date: 2022-05-04

Last Posted Date: 2024-02-07

Lead Sponsor: Chulalongkorn University

Target Recruit Count: 147

Registration Number: NCT05360615

Locations: 🇹🇭
Central Chest Institute of Thailand, Nonthaburi, Mueang Nonthaburi District, Thailand

Efficacy and Safety of Nasal Spray Solution Containing Human IgG1 Anti-COVID-19 Antibody Cocktail

Not Applicable

Completed

Conditions: SARS-CoV-2 Acute Respiratory Disease
SARS CoV 2 Infection

Interventions: Device: Human IgG1 anti-SARS-CoV-2 antibody cocktail
Device: Placebo

First Posted Date: 2022-05-03

Last Posted Date: 2022-07-07

Lead Sponsor: Chulalongkorn University

Target Recruit Count: 50

Registration Number: NCT05358873

Locations: 🇹🇭
National Cancer Institute of Thailand, Bangkok, Thailand

Clinical Outcomes of Low Dose PK-guided EHL FVIII Concentrates Versus Standard Prophylaxis in Severe Haemophilia A

Phase 4

Completed

Conditions: Severe Hemophilia A Without Inhibitor

Interventions: Drug: Extended half-life FVIII concentrates with PK-guided dosing
Drug: standard half-life FVIII concentrates with weight-based dosing

First Posted Date: 2022-03-16

Last Posted Date: 2022-07-20

Lead Sponsor: Chulalongkorn University

Target Recruit Count: 15

Registration Number: NCT05281185

Locations: 🇹🇭
Pediatric department, Faculty of medicine, Chulalongkorn University, Pathum Wan, Bangkok, Thailand

Safety and Immunogenicity of ChulaCov19 BNA159 mRNA Vaccine

Phase 1

Recruiting

Conditions: Tolerability of 25 ug of ChulaCov19-BNA159 mRNA Vaccine
Immune Response of 25 ug of ChulaCov19-BNA159 mRNA Vaccine
Safety of 25 ug of ChulaCov19-BNA159 mRNA Vaccine
Immune Response of 50 ug of ChulaCov19-BNA159 mRNA Vaccine
Assess Which Dose is Appropriate to Use
Safety of 50 ug of ChulaCov19-BNA159 mRNA Vaccine
Tolerability of 50 ug of ChulaCov19-BNA159 mRNA Vaccine

Interventions: Biological: ChulaCov19 BNA159 mRNA vaccine

First Posted Date: 2022-02-09

Last Posted Date: 2023-02-10

Lead Sponsor: Chulalongkorn University

Target Recruit Count: 24

Registration Number: NCT05231369

Locations: 🇹🇭
Chula Clinical Research Center (Chula CRC), Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand
🇹🇭
Academic Clinical Research Office (ACRO) Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand

Effectiveness and Safety of High Frequency Electrotherapy in Patients With Meibomian Gland Dysfunction

Not Applicable

Conditions: Meibomian Gland Dysfunction

Interventions: Device: Rexon-eye

First Posted Date: 2021-12-21

Last Posted Date: 2021-12-21

Lead Sponsor: Chulalongkorn University

Target Recruit Count: 80

Registration Number: NCT05165342

Locations: 🇹🇭
Chulalongkorn University, Bangkok, Thailand

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy